Design and synthesis of two new steroid derivatives with biological activity on heart failure via the M2-muscarinic receptor activation
| 期刊 | Steroids |
| 发表日期 | 2020-06 |
| 作者 | Lauro Figueroa-Valverde; Maria Lopez-Ramos; Tomas Lopez-Gutierrez; Francisco Diaz Cedillo; Rolando Garcia-Martinez; Marcela Rosas-Nexticapa; Virginia Mateu-Armand; Alejandra Garcimarero-Espino E; Yaz… |
| DOI | 10.1016/j.steroids.2020.108620 |
| PMID | 32119871 |
原始摘要
Several drugs have been prepared to treat of heart failure using some protocols which require dangerous reagents and specific conditions. The aim of this study was to synthesize a series of steroid derivatives (compounds 2 to 18) using some chemical strategies. The biological activity of steroid derivatives against heart failure was evaluated using an ischemia/reperfusion model. In addition, the effect exerted by compounds 4 or 5 on left ventricular pressure was evaluated in the absence or presence of yohimbine, butaxamine and methoctramine. The results showed that 1) both compounds 4 or 5 significantly decrease the heart failure (translated as infarct area) compared with the compounds 2, 3 and 6-18. In addition, the compound 4 and 5 decreased the left ventricular pressure in a dose-dependent manner and this effect was significantly inhibited in the presence of methoctramine (p = 005). In conclusion, the compounds 4 or 5 decrease both the infarct area and left ventricular pressure via M-muscarinic receptor activation.
| 撤稿日期 | 2026-07-16 |
| 撤稿期刊 | Steroids |
| 发布机构 | United States |
| 通知PMID | 42463396 |
Retraction notice to "Design and synthesis of two new steroid derivatives with biological activity on heart failure via the M2-muscarinic receptor activation" [Steroids 158 (2020) 108620]